Interleukin 1β Enhances Invasive Ability of Gastric Carcinoma through Nuclear Factor-κB Activation

Clinical Cancer Research

Volumn 10, Issue 5, 2004, Pages 1853-1859

  Yamanaka, Naoki ^a   Morisaki, Takashi ^a   Nakashima, Hiroshi ^a   Tasaki, Akira ^a   Kubo, Makoto ^a   Kuga, Hirotaka ^a   Nakahara, Chihiro ^a   Nakamura, Katsuya ^a   Noshiro, Hirokazu ^a   Yao, Takashi ^a   Tsuneyoshi, Masazumi ^a   Tanaka, Masao ^a   Katano, Mitsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; PYRROLIDINE DITHIOCARBAMATE; COLLAGEN; INTERLEUKIN 1; LAMININ; MATRIGEL; PROTEOGLYCAN;

ARTICLE; CANCER INVASION; CANCER SURGERY; CARCINOMA CELL; CELL STRAIN; CELL STRAIN GCTM 1; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GASTRECTOMY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; TUMOR ASSOCIATED LEUKOCYTE; WESTERN BLOTTING; DRUG ANTAGONISM; DRUG COMBINATION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

BASE SEQUENCE; CELL LINE, TUMOR; COLLAGEN; DRUG COMBINATIONS; HUMANS; INTERLEUKIN-1; LAMININ; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NF-KAPPA B; OLIGONUCLEOTIDES, ANTISENSE; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS;

EID: 4644354477     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-03-0300     Document Type: Article

References (49)

1. Vermeulen, L., De Wilde, G., Notebaert, S., Vanden Berghe, W., and Haegeman, G. Regulation of the transcriptional activity of the nuclear factor-κB p65 subunit. Biochem. Pharmacol., 64: 963-970, 2002.
2. Chen, F., Castranova, V., and Shi, X. New insights into the role of nuclear factor-κB in cell growth regulation. Am. J. Pathol., 159: 387-397, 2001.
3. Karin, M., Cao, Y., Greten, F. R., and Li, Z. W. NF-κB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer, 2: 301-310, 2002.
4. Karin, M., and Lin, A. NF-κB at the crossroads of life and death. Nat. Immunol., 3: 221-227, 2002.
5. Haefner, B. NF-κB: arresting a major culprit in cancer. Drug Discov. Today, 7: 653-663, 2002.
6. Bharti, A. C., and Aggarwal, B. B. Nuclear factor-κB and cancer: its role in prevention and therapy. Biochem. Pharmacol., 64: 883-888, 2002.
7. Li, X., and Stark, G. R. NFκB-dependent signaling pathways. Exp. Hematol., 30: 285-296, 2002.
8. Wang, W., Abbruzzese, J. L., Evans, D. B., and Chiao, P. J. Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA. Oncogene. 18: 4554-4563, 1999.
9. Biswas, D. K., Dai, S. C., Cruz, A., Weiser, B., Graner, E., and Pardee, A. B. The nuclear factor κB (NF-κB): A potential therapeutic target for estrogen receptor negative breast cancers. Proc. Natl. Acad. Sci. USA, 98: 10386-10391, 2001.
10. Lind, D. S., Hochwald, S. N., Malaty, J., Rekkas, S., Hebig. P., Mishra, G., Moldawer, L. L., Copeland, E. M., III, and Mackay, S. NF-κB is upregulated in colorectal cancer. Surgery, 130: 363-369, 2001.
11. Tai, D. I., Tsai, S. L., Chang, Y. H., Huang, S. N., Chen, T. C., Chang, K. S., and Liaw, Y. F. Constitutive activation of nuclear factor κB in hepatocellular carcinoma. Cancer (Phila.), 89: 2274-2281, 2000.
12. Sasaki, N., Morisaki, T., Hashizume, K., Yao, T., Tsuneyoshi, M., Noshiro, H., Nakamura, K., Yamanaka, T., Uchiyama, A., Tanaka, M., and Katano, M. Nuclear factor-κB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin. Cancer Res., 7: 4136-4142, 2001.
13. Coussens, L. M., and Werb, Z. Inflammation and cancer. Nature (Lond.), 420: 860-867, 2002.
14. Balkwill, F., and Mantovani, A. Inflammation and cancer: back to Virchow? Lancet, 357: 539-545, 2001.
15. Farrow, B., and Evers, B. M. Inflammation and the development of pancreatic cancer. Surg. Oncol., 10: 153-169, 2002.
16. Schwartsburd, P. M. Chronic inflammation as inductor of pro-cancer microenvironment: pathogenesis of dysregulated feedback control. Cancer Metastasis Rev., 22: 95-102, 2003.
17. Nakae, S., Asano, M., Horai, R., and Iwakura, Y. Interleukin-1β, but not interleukin-1α, is required for T-cell-dependent antibody production. Immunology, 104: 402-409, 2001.
18. Bird, S., Zou, J., Wang, T., Munday, B., Cunningham, C., and Secombes, C. J. Evolution of interleukin-1β. Cytokine Growth Factor Rev., 13: 483-502, 2002.
19. Beppu, K., Morisaki, T., Matsunaga, H., Uchiyama, A., Ihara, E., Hirano, K., Kanaide, H., Tanaka, M., and Katano, M. Inhibition of interferon-γ -activated nuclear factor-κB by cyclosporin A: a possible mechanism for synergistic induction of apoptosis by interferon-γ and cyclosporin A in gastric carcinoma cells. Biochem. Biophys. Res. Commun., 305: 797-805, 2003.
20. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
21. Huang, H. Y., Wen, Y., Kruessel, J. S., Raga, F., Soong, Y. K., and Polan, M. L. Interleukin (IL)-1β regulation of IL-1β and IL-1 receptor antagonist expression in cultured human endometrial stromal cells. J. Clin. Endocrinol. Metab., 86: 1387-1393, 2001.
22. Zhang, H., Morisaki, T., Matsunaga, H., Sato, N., Uchiyama, A., Hashizume, K., Nagumo, F., Tadano, J., and Katano, M. Protein-bound polysaccharide PSK inhibits tumor invasiveness by down-regulation of TGF-β1 and MMPs. Clin. Exp. Metastasis, 18: 343-352, 2000.
23. Banerjee, S., Bueso-Ramos, C., and Aggarwal, B. B., Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-κB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res., 62: 4945-4954, 2002.
24. Razandi, M., Pedram, A., Park, S. T., and Levin, E. R. Proximal events in signaling by plasma membrane estrogen receptors. J. Biol. Chem., 278: 2701-2712, 2003.
25. Brennan, P., and O'Neill, L. A. 2-Mercaptoethanol restores the ability of nuclear factor κB (NFκB) to bind DNA in nuclear extracts from interleukin 1-treated cells incubated with pyrollidine dithiocarbamate (PDTC). Evidence for oxidation of glutathione in the mechanism of inhibition of NFκB by PDTC. Biochem. J., 320: 975-981, 1996.
26. Estève, P. O., Chicoine, É., Robledo, O., Aoudjit, F., Descoteaux, A., Potworowski, E. F., and St-Pierre, Y. Protein kinase C-ζ regulates transcription of the matrix metalloproteinase-9 gene induced by IL-1 and TNF-α in glioma cells via NF-κB. J. Biol. Chem., 277: 35150-35155, 2002.
27. Hah, N., and Lee, S. T. An absolute role of the PKC-dependent NF-βB activation for induction of MMP-9 in hepatocellular carcinoma cells. Biochem. Biophys. Res. Commun., 305: 428-433, 2003.
28. Arend, W. P., Gordon, D. F., Wood, W. M., Janson, R. W., Joslin, F. G., and Jameel, S. IL-1β production in cultured human monocytes is regulated at multiple levels. J. Immunol., 143: 118-126, 1989.
29. Saijio, Y., Tanaka, M., Miki, M., Usui, K., Suzuki, T., Maemondo, M., Hong, X., Tazawa, R., Kikuchi, T., Matsushima, K., and Nukiwa, T. Proinflammatory cytokine IL-1β promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction. J. Immunol., 169: 469-475, 2002.
30. Maihöfner, C., Charalambous, M. P., Bhambra, U., Lightfoot, T., Geisslinger, G., Gooderham, N. J., and the Colorectal Cancer Group. Expression of cyclooxygenase-2 parallels expression of interleukin-1β, interleukin-6 and NF-κB in human colorectal cancer. Carcinogenesis (Lond.), 24: 665-671, 2003.
31. Wahl, L. M., and Kleinman, H. K. Tumor-associated macrophages as targets for cancer therapy. J. Natl. Cancer Inst. (Bethesda), 90: 1583-1584, 1998.
32. Schoppmann, S. F., Birner, P., Stöckl, J., Kalt, R., Ullrich, R., Caucig, C., Kriehuber, E., Nagy, K., Alitalo, K., and Kerjaschki, D. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am. J. Pathol., 161: 947-956, 2002.
33. Bortolami, M., Venturi, C., Giacomelli, L., Scalerta, R., Bacchetti, S., Marino, F., Floreani, A., Lise, M., Naccarato, R., and Farinati, F. Cytokine, infiltrating macrophage and T cell-mediated response to development of primary and secondary human liver cancer. Dig. Liver Dis., 34: 794-801, 2002.
34. Liss, C., Fekete, M. J., Hasina, R., Lam, C. D., and Lingen, M. W. Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages. Int. J. Cancer, 93: 781-785, 2001.
35. Ciotti, P., Rainero, M. L., Nicolo, G., Spina, B., Garre, C., Casabona, F., Santi, P. L., and Bianchi-Scarra, G. Cytokine expression in human primary and metastatic melanoma cells: analysis in fresh bioptic specimens. Melanoma Res., 5: 41-47, 1995.
36. Kostura, M. J., Tocci, M. J., Limjuco, G., Chin, J., Cameron, P., Hillman, A. G., Chartrain, N. A., and Schmidt, J. A. Identification of a monocyte specific pre-interleukin 1β convertase activity. Proc. Natl. Acad. Sci. USA, 86: 5227-5231, 1989.
37. von Schweinitz, D., Hadam, M. R., Welte, K., Mildenberger, H., and Pietsch, T. Production of interleukin-1β and interleukin-6 in hepatoblastoma. Int. J. Cancer, 53: 728-734, 1993.
38. Huleihel, M., Maymon, E., Piura, B., Prinsloo, I., Benharroch, D., Yanai-Inbar, I., and Glezerman, M. Distinct patterns of expression of interleukin-1 α and β by normal and cancerous human ovarian tissues. Eur. Cytokine Netw., 8: 179-187, 1997.
39. Etoh, T., Shibuta, K., Barnard, G. F., Kitano, S., and Mori, M. Angiogenin expression in human colorectal cancer: the role of focal macrophage infiltration. Clin. Cancer Res., 6: 3545-3551, 2000.
40. Arlt, A., Vorndamm, J., Müerköster, S., Yu, H., Schmidt, W. E., Fölsch, U. R., and Schäfer, H. Autocrine production of interleukin 1β confers constitutive nuclear factor κB activity and chemoresistance in pancreatic carcinoma cell lines. Cancer Res., 62: 910-916, 2002.
41. Chong, J. M., Sakuma, K., Sudo, M., Osawa, T., Ohara, E., Uozaki, H., Shibahara, J., Kuroiwa, K., Tominaga, S., Hippo, Y., Aburatani, H., Funata, N., and Fukayama, M. Interleukin-1β expression in human gastric carcinoma with Epstein-Barr virus infection. J. Virol., 76: 6825-6831, 2002.
42. Maeda, S., Akanuma, M., Mitsuno, Y., Hirata, Y., Ogura, K., Yoshida, H., Shiratori, Y., and Omata, M. Distinct mechanism of Helicobacter pylori-mediated NF-κB activation between gastric cancer cells and monocytic cells. J. Biol. Chem., 276: 44856-44864, 2001.
43. Egeblad, M., and Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer, 2: 161-174, 2002.
44. Mitropoulou, T. N., Tzanakakis, G. N., Kletsas, D., Kalofonos, H. P., and Karamanos, N. K. Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells. Int. J. Cancer, 104: 155-160, 2003.
45. Look, M. P., van Putten, W. L., Duffy, M. J., Harbeck, N., Christensen, I. J., Thomssen, C., Kates, R., Spyratos, F., Fernö, M., Eppenberger-Castori, S., Sweep, C. G., Ulm, K., Peyrat, J. P., Martín, P. M., Magdelenat, H., Brünner, N., Duggan, C., Lisboa, B. W., Bendahl, P. O., Quillien, V., Daver, A., Ricolleau, G., Meijer-van Gelder, M. E., Manders, P., Fiets, W. E., Blankenstein, M. A., Broët, P., Romain, S., Daxenbichler, G., Windbichler, G., Cufer, T., Borstnar, S., Kueng, W., Beex, L. V., Klijn, J. G., O'Higgins, N., Eppenberger, U., Jänicke, F., Schmitt, M., and Foekens, J. A. Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. J. Natl. Cancer Inst. (Bethesda), 94: 116-128, 2002.
46. Ramos-DeSimone, N., Hahn-Dantona, E., Sipley, J., Nagase, H., French, D. L., and Quigley, J. P. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J. Biol. Chem., 274: 13066-13076, 1999.
47. Torii, A., Kodera, Y., Ito, M., Shimizu, Y., Hirai, T., Yasui, K., Morimoto, T., Yamamura, Y., Kato, T., Hayakawa, T., Fujimoto, N., and Kito, T. Matrix metalloproteinase 9 in mucosally invasive gastric cancer. Gastric Cancer, 1: 142-145, 1998.
48. Maquoi, E., Munaut, C., Colige, A., Lambert, C., Frankenne, F., Nöe, A., Grams, F., Krell, H. W., and Foidart, J. M. Stimulation of matrix metalloproteinase-9 expression in human fibrosarcoma cells by synthetic matrix metalloproteinase inhibitors. Exp. Cell Res., 275: 110-121, 2002.
49. Qian, L. W., Mizumoto, K., Urashima, T., Nagai, E., Maehara, N., Sato, N., Nakajima, M., and Tanaka, M. Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023. Clin. Cancer Res., 8: 1223-1227, 2002.